Gyselle 20, Tabletten - 21 Swissmedic Key 69016001 Registration Holder Spirig HealthCare AG Name Gyselle 20, Tabletten Date of registration 10.08.2023 Introduction of Sequence 10.08.2023 ATC-Classification Gestodene and Ethinylestradiol (G03AA10) Revision date WHO WHO-DDD Valid until 09.08.2028 Index Therapeuticus (BSV) Show package size 21 Index Therapeuticus (Swissmedic) 09.02.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680690160012 Medication Code Synthetika Pharmacode Disponibility
Composition gestodenum 0.075 mg, ethinylestradiolum 0.02 mg, lactosum monohydricum 59.12 mg, cellulosum microcristallinum, povidonum K 30, polacrilinum kalicum, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Ethinyl Estradiol 0.02 mg Gestoden 0.075 mg
Inactive agents Dose Cellulosum Microcristallinum Lactose Monohydrate 59.12 mg Magnesii Stearas Polacrilinum Kalicum Povidonum K 30 Pro Compresso
Source Data was imported : 05.09.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
